Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

NCT06376968 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Dialysis

Interventions

DEVICE: BioLogic Fusion

Sponsor

B.Braun Avitum AG